Therapy of Preconditioned Autologous BMMSCs for Patients With Ischemic Heart Disease
A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT02504437
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 1/2
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT02504437
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT02504437. Randomized; double masking; primary purpose treatment. Start 2015-11 (registry gives no type); primary completion 2017-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Therapy of Preconditioned Autologous BMMSCs for Patients With Ischemic Heart Disease
- Acronym
- TPAABPIHD
- Condition
- Myocardial Infarction
- Condition
- Acute Myocardial Infarction
- Condition
- Ischemic Cardiomyopathy
- Intervention (Biological)
- BMMSCs
- Lead sponsor
- Academy Military Medical Science, China
- Collaborator
- Sun Yat-sen University
Record details
- Record id
cardio:ct-nct02504437- Content hash
fd93b4ff54f4819a6ef9c3622925b9d9f7137eef4fb4bb5af9a4834a6fbce625